CDNA
CareDx, Inc · Healthcare · Medical - Diagnostics & Research
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +1.6% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 7.59K | $472,199 | n/a | n/a |
| Q2 2026 | 95 | +15 | 33.94M | $966.70M | +15 | n/a |
| Q1 2026 | 83 | +3 | 34.73M | $602.98M | +6 | −3 |
| Q4 2025 | 80 | +2 | 35.05M | $660.43M | +2 | n/a |
| Q3 2025 | 16 | -1 | 19.38M | $281.84M | n/a | −1 |
| Q2 2025 | 14 | -2 | 18.42M | $359.99M | n/a | −2 |
| Q1 2025 | 13 | -1 | 10.08M | $178.96M | n/a | −1 |
| Q4 2024 | 14 | 0 | 12.01M | $257.21M | +1 | −1 |
| Q3 2024 | 13 | +2 | 9.17M | $286.29M | +2 | n/a |
| Q2 2024 | 11 | n/a | 12.97M | $201.49M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 2.66M | n/a | $56.93M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | ARK Investment Management ✦ | 2.41M | -19.4% | $51.58M | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 1.43M | +15.9% | $30.66M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 1.23M | +0.5% | $26.43M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 5 | D. E. Shaw & Co. ✦ | 1.15M | -15.5% | $24.60M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 6 | Millennium Management ✦ | 621.31K | +37.8% | $13.30M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 547.27K | +65.9% | $11.72M | 0.0% | ▲ Add | 3 | SEC ↗ ×4 |
| 8 | Citadel Advisors ✦ | 510.04K | +23.9% | $10.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 468.84K | +50.0% | $10.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 465.67K | +81.5% | $9.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Marshall Wace ✦ | 289.46K | -21.4% | $6.20M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 12 | Wellington Management ✦ | 165.36K | -14.6% | $3.54M | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 13 | Arrowstreet Capital ✦ | 34.16K | Nieuw | $731,408 | 0.0% | New | 1 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 27.12K | +12.5% | $581,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Arrowstreet Capital | $731,408 | 0.0% |
Verlaten
| Gotham Asset Management | $262,446 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 189 houders, 52.20M aandelen, $899.83M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.